Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin versus placebo in adults with type 1 diabetes
IRCT20080902001181N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in diabetes mellitus type 1 (T1D) comparing Sitagliptin + insulin with Placebo + insulin (2 arms). Primary endpoints: Total insulin dose, Blood sugar and 1 more. Started Mar 2021; status: completed.
02
Drugs
sitagliptin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT20080902001181N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080902001181N3.